Klinische studies

Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy. (STEREOBED)

Bekijk de flyer

Meer informatie.

Preoperative Radiation Therapy and Immediate Breast Reconstruction, a phase 3 randomized controlled trial in the Belgian population.

Bekijk de flyer

Meer informatie.

Phase III randomized trial for high-risk asymptomatic or minimally symptomatic bone metastases: Early radiotherapy versus observation

Bekijk de flyer

 

sTereotactic bOdy Radiation therapy for inoperable nonmetastasized PancrEatic aDenocarcinOma: a randomized phase II study 

Bekijk de flyer

Meer informatie.

High-dose Pleural Radiotherapy in Lung-Sparing Multimodality Therapy for Malignant Pleural Mesothelioma

An international Prospective Open-label, Multi-center, Randomized Phase III Study comparing [177Lu] Lu-PSMA-617 versus Observation to delay castration or disease recurrence in adult male patients with PSMA positive Oligometastatic Prostate Cancer (OMPC)

Bekijk de flyer

Meer informatie.

Efficacy and safety of short-course radiotherapy (SCRT) versus total neoadjuvant therapy in older patients with locally advanced rectal cancer: a multicentre open-label, randomised pragmatic clinical trial.

 

Bekijk de flyer

Meer informatie

Treatment of Hig-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial

Bekijk de flyer

Meer informatie

 

ReCare is a cohort within E²-RADIatE and focuses on cancer patients who are treated with high-dose re-irradiation.

Meer informatie

CArdiac STereotactic radiation treatment for Ablation of ventRicular tachycardia

Bekijk de flyer

Neurocognition after radiotherapy in adult brain and base of skull tumours

 

Phase II prospective trial to evaluate the impact of 18F-FDG-PET-CT in stratifying patients with primary muscle invasive bladder cancer and tailoring the treatment accordingly. 

Meer informatie

Profylactische cerebrale bestraling of actieve opvolging met magnetische resonantiebeeldvorming bij patiënten met kleincellige longkanker (PRIMALung-studie).

Meer informatie

Stereotactic bodyradiotherapy in addition to standard of care tretment in patients with rare oligometastatic cancers (OligoRARE): a randomized, phase 3, open-label trial

Meer informatie

A pragmatic observational cohort study to evaluate radical radiotherapy for oligo-metastatic cancer patients

Meer informatie

Stereotactic body radiotherapy with or without Darolutamide for OligoRecurrent prostate cancer: a randomized phase II trial

 

Randomized Phase II study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Maintenance Durvalumab versus Durvalumab plus Radiotherapy followed by Maintenance Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer

 

 

Neo-adjuvant chemotherapy combined with SBRT to the primary tumour +/- durvalumab (MEDI4736), +/- oleclumab (MEDI9447) in luminal B breast cancer: a phase II randomized trial.

 

A Randomized, Controlled, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients with PSMA-PET-Positive Hormone-Sensitive Prostate Cancer, with an Observational Follow-up of PSMA-PET-Negative Patients Protocol

Meer informatie

A Phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of andorgen-deprivation therapy (ADT) with LHRH agonist or antagonist versus anti-androgen therapy (AAT) with apalutamide in patients with biochemical progression after radical prostatectomy.